Feedback / Questions
lutetium lu-177 tezuvotide tetraxetan (177Lu-rhPSMA-10.1) - Bracco
https://www.prnewswire.com/news-releases/first-patients-in-the-uk-receive-doses-of-blue-earth-therapeutics-investigational-radiopharmaceutical-therapy-lutetium-177lu-rhpsma-10-1-injection-for-metastatic-castrate-resistant-prostate-cancer-302661434.html
Jan 15, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next